307 related articles for article (PubMed ID: 132382)
21. Alloxan uptake by isolated rat islets of Langerhans.
Weaver DC; McDaniel ML; Lacy PE
Endocrinology; 1978 Jun; 102(6):1847-55. PubMed ID: 369835
[TBL] [Abstract][Full Text] [Related]
22. Interactions of diabetogenic compounds: cyproheptadine and alloxan.
Chatterjee AK; Varayotha V; Fischer LJ
Fundam Appl Toxicol; 1991 Jan; 16(1):188-97. PubMed ID: 2019344
[TBL] [Abstract][Full Text] [Related]
23. New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
Kawada J; Toide K; Nishida M; Yoshimura Y; Tsujihara K
Diabetes; 1986 Jan; 35(1):74-7. PubMed ID: 2934286
[TBL] [Abstract][Full Text] [Related]
24. Effect of pharmacological doses of 3-0-methyl-D-glucose and 2-deoxy-D-glucose on rat brain glucose and lactate.
Miller LP; Villeneuve JB; Braun LD; Oldendorf WH
Stroke; 1986; 17(5):957-61. PubMed ID: 3764967
[TBL] [Abstract][Full Text] [Related]
25. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Anderson T; Schein PS; McMenamin MG; Cooney DA
J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of protection from alloxan diabetes provided by n-butanol.
Schauberger CW; Thies RL; Fischer LJ
J Pharmacol Exp Ther; 1977 May; 201(2):450-5. PubMed ID: 323464
[TBL] [Abstract][Full Text] [Related]
27. Recovery from impairment in feeding response to glucoprivic stimuli and in sensitivity to diabetogenic agents in riboflavin-repleted rats.
Matsuo T; Shimakawa K; Suzuoki Z
J Nutr; 1983 Sep; 113(9):1784-90. PubMed ID: 6224919
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.
Lenzen S; Mirzaie-Petri M
Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):532-6. PubMed ID: 1470224
[TBL] [Abstract][Full Text] [Related]
29. Anomeric specificty of 3-0-methyl-D-glycopyranose against alloxan diabetes.
Rossini AA; Cahill GF; Jeanioz DA; Jeanioz RW
Science; 1975 Apr; 188(4183):70-1. PubMed ID: 1167978
[TBL] [Abstract][Full Text] [Related]
30. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
31. Studies of streptozotocin-induced insulitis and diabetes.
Rossini AA; Like AA; Chick WL; Appel MC; Cahill GF
Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2485-9. PubMed ID: 142253
[TBL] [Abstract][Full Text] [Related]
32. Complete protection from low-dose streptozotocin-induced diabetes in mice.
Rossini AA; Williams RM; Appel MC; Like AA
Nature; 1978 Nov; 276(5684):182-4. PubMed ID: 154064
[No Abstract] [Full Text] [Related]
33. Energy metabolism and T-cell-mediated cytolysis. II. Selective inhibition of cytolysis by 2-deoxy-D-glucose.
MacDonald HR
J Exp Med; 1977 Sep; 146(3):710-9. PubMed ID: 302305
[TBL] [Abstract][Full Text] [Related]
34. Glucokinase in pancreatic B-cells and its inhibition by alloxan.
Lenzen S; Tiedge M; Panten U
Acta Endocrinol (Copenh); 1987 May; 115(1):21-9. PubMed ID: 3296598
[TBL] [Abstract][Full Text] [Related]
35. Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans.
Weaver DC; McDaniel ML; Naber SP; Barry CD; Lacy PE
Diabetes; 1978 Dec; 27(12):1205-14. PubMed ID: 363492
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
Gaulton GN; Schwartz JL; Eardley DD
Diabetologia; 1985 Oct; 28(10):769-75. PubMed ID: 2933286
[TBL] [Abstract][Full Text] [Related]
37. Islet cell membrane alteration by diabetogenic drugs.
Orci L; Amherdt M; Malaisse-Lagae F; Ravazzola M; Malaisse WJ; Perrelet A; Renold AE
Lab Invest; 1976 May; 34(5):451-4. PubMed ID: 131879
[TBL] [Abstract][Full Text] [Related]
38. Alloxan-glucose interaction: effect on incorporation of 14C-leucine into pancreatic islets of rat.
Bansal R; Ahmad N; Kidwai JR
Acta Diabetol Lat; 1980; 17(2):135-43. PubMed ID: 7004041
[TBL] [Abstract][Full Text] [Related]
39. Molecular target structures in alloxan-induced diabetes in mice.
im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H
Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914
[TBL] [Abstract][Full Text] [Related]
40. 1-Anilino-8-naphthalene sulfonate as a probe of conformational changes of rabbit intestinal brush border membranes on addition of salts and sugars.
Ohyashiki T; Mohri T
J Biochem; 1979 Mar; 85(3):857-63. PubMed ID: 429268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
